Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk
NCT06337279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3820
Last updated 2024-03-29
Summary
The Systemic Oxidative Stress Score (SOSS) , a comprehensive score reflecting the oxidative stress conditions in the microenvironment, can independently and effectively predict tumor burden and long-term prognosis in GC patients. Nomograms based on SOSS provide a potential and promising model for risk stratification and guiding the implementation of treatment decisions.
Conditions
Sponsors & Collaborators
-
Fujian Medical University Union Hospital
collaborator OTHER -
Fujian Medical University
lead OTHER
Principal Investigators
-
Changming Huang, Prof. · Fujian Medical University Union Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-10
- Primary Completion
- 2023-08-20
- Completion
- 2024-03-20
Countries
- China
Study Locations
More Related Trials
-
Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients
NCT06629714 ·Status: COMPLETED
-
Predictive Value of Air Pollution and Metabolomics for Gastric Cancer.
NCT06641700 ·Status: ACTIVE_NOT_RECRUITING
-
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT06699979 ·Status: RECRUITING
-
Molecular Profiling in Small Cell Lung Cancer
NCT03162705 ·Status: UNKNOWN
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
NCT07026669 ·Status: RECRUITING
-
Oral Microbiome Diagnostics of Lung Cancer
NCT06270992 ·Status: RECRUITING
-
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients
NCT06339307 ·Status: COMPLETED
-
Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
NCT06561178 ·Status: RECRUITING
-
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
NCT05214885 ·Status: RECRUITING
-
Methylation-specific PCR Test for Early Screening and Early Diagnosis of Nasopharyngeal Carcinoma
NCT06367049 ·Status: COMPLETED
-
Analysis of Plasma Tumor DNA in Lung Cancer Patients
NCT01930474 ·Status: UNKNOWN
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Association Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma
NCT01240369 ·Status: UNKNOWN
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735 ·Status: UNKNOWN
-
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NCT05701787 ·Status: RECRUITING
-
Perioperative Treatment Outcomes of Early NSCLC
NCT06610240 ·Status: ENROLLING_BY_INVITATION
-
Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant Therapy
NCT06573307 ·Status: COMPLETED
-
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
NCT06503042 ·Status: NOT_YET_RECRUITING
-
Prospective Screening Programme for Malignant Tumors
NCT04230200 ·Status: UNKNOWN
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Detection Cell Free DNA in Lung Cancer Patients
NCT02738593 ·Status: UNKNOWN